Short description
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.
Description
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.
They focus on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Their first product candidates in development target primary optical atrophy. They are further evaluating them for use in serious neurological / neuromuscular diseases such as ALS, Huntington's, Alzheimer’s and Parkinson’s disease.
Their team is composed of passionate and innovative founders and experts who have solid track records in drug development and clinical research in multinational pharmaceutical companies or management experience in international technology enterprises. Their determination in bringing life-changing treatments to patients encompasses everything they do.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Allschwil, Basel-Landschaft, Switzerland, Europe
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noway Youcantaccess, Nopepepe
Sign in for full access
Founders
David Guan, Dong Yuhong